Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy

Clinical Cancer Research

Volumn 3, Issue 12 II, 1997, Pages 2703-2707

  Mendelsohn, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 225; PACLITAXEL; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG POTENTIATION; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MITOSIS INHIBITION; NONHUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR XENOGRAFT;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS, PHASE I; COMBINED MODALITY THERAPY; DOWN-REGULATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0031409362     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Barnes, D., and Sato, G. Serum-free cell culture: a unifying approach. Cell, 22: 649-655, 1980.
2. Carpenter, G., and Cohen, S. Epidermal growth factor. J. Biol. Chem., 265: 7709-7712, 1990.
3. Sporn, M. B., and Todaro, G. J. Autocrine secretion and malignant transformation of cells. N. Engl. J. Med. 303: 878-880, 1980.
4. Kawamoto, T. K., Sato, J. D., Le, A., Polikoff, J., Sato, G. H., and Mendelsohn, J. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc. Natl. Acad. Sci. USA, 80: 1337-1341, 1983.
5. Sato, J. D., Kawamoto, T., Le, A. D., Mendelsohn, J., Polikoff, J., and Sato, G. H. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol. Biol. Med. 1: 511-529, 1983.
6. Kawamoto, T., Mendelsohn, J., Le, A., Sato, G. H., Lazar, C. S., and Gill, G. N. Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma in A431 cells. J. Biol. Chem., 259: 7761-7766, 1984.
7. Gill, G. N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., McLeod, C., and Mendelsohn, J. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem. 259: 7755-7760, 1984.
8. Arteaga, C. L., Coronado, E., and Osborne, C. K. Blockade of the epidermal growth factor receptor inhibits transforming growth factor-alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer. Mol. Endocrinol., 2: 1064-1069, 1988.
9. Ennis, B. W., Valverius, E. M., Bates, S. E., Lippman, M. E., Bellot, F., Kris, R., Schlessinger, J., Masui, H., Goldenberg, A., Mendelsohn, J., and Dickson, R. B. Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. Mol. Endocrinol., 3: 1830-1838, 1989.
10. Masui, H., Boman, B., Hyman, J., Castro, L., and Mendelsohn, J. Treatment with anti-EGF receptor monoclonal antibody causes regression of DiFi human colorectal carcinoma xenografts. Proc. Am. Assoc. Cancer Res., 32: 394, 1991.
11. Karnes, W. E., Jr., Walsh, J. H., Wu, S. V., Kim, R. S., Martin, M. G., Wong, H. C., Mendelsohn, J., Park, J., and Cuttitta, F. Autonomous proliferation of colon cancer cells that coexpress transforming growth factor a and its receptor. Variable effects of receptor-blocking antibody. Gastroenterology, 102: 474-485, 1992.
12. Wu, X., Fan, Z., Masui, H., Rosen, N., and Mendelsohn, J. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J. Clin. Invest., 95: 1897-1905, 1995.
13. Reiss, M., Stash, E. B., Vellucci, V. F., and Zhou, Z. Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells. Cancer Res., 51: 6254-6262, 1992.
14. Atlas, I., Mendelsohn, J., Baselga, J., Fair, W. R., Masui, H., and Kumar, R. Growth regulation of human renal carcinoma cells: role of transforming growth factor-α. Cancer Res., 52: 3335-3339, 1992.
15. Hofer, D. R., Sherwood, E. R., Bromberg, W. D., Mendelsohn, J., Lee, C., and Kozlowski, J. M. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor. Cancer Res., 51: 2780-2785, 1991.
16. 1 arrest in prostatic cancer cell line DU145. Cancer Res., 56: 3666-3669, 1996.
17. Markowitz, S. D., Molkentin, K., Gerbic, C., Jackson, J., Stellato, T., and Willson, J. K. V. Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor receptor in normal and adenomatous human colon epithelium. J. Clin. Invest., 86: 356-362, 1990.
18. Chou, J., Fan, Z., Koff, A., and Mendelsohn, J. EGF receptor blockade induces reversible growth arrest and changes in proteins that regulate the cell cycle in human mammary epithelial cells. Proc. Am. Assoc. Cancer Res., 37: 10, 1996.
19. Mendelsohn, J., Masui, H., and Goldenberg, A. Anti-epidermal growth factor receptor monoclonal antibodies may inhibit A431 tumor cell proliferation by blocking autocrine pathway. Trans. Assoc. Am. Phys., C: 173-178, 1987.
20. Van de Vijver, M. J., Kumar, R., and Mendelsohn, J. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. J. Biol. Chem., 266: 7503-7508, 1991.
21. Xu, Y. H., Ishii, S., Clark, A. J., Sullivan, M., Wilson, R. K., Ma, D. P., Roe, B. A., Merlino, G. T., and Pastan, I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature (Lond.), 309: 806-810, 1984.
22. Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., and Waterfield, M. D. Close similarity of epidermal growth factor receptor and v-ere-B oncogene protein sequences. Nature (Lond.), 307: 521-527, 1984.
23. Mendelsohn, J., and Lippman, M. Principles of molecular cell biology of cancer: growth factors. In: V. T. DeVita, Jr., S. Hellman, and S. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 114-133. Philadelphia: J. B. Lippincott Co., 1993.
24. Neal, D. E., Bennett, M. K., Hall, R. R., Marsh, C., Abel, P. D., Sainsbury, J. R. C., and Harris, A. L. Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet, 1: 366-368, 1985.
25. Harris, A. L., Nicholson, S., Sainsbury, J. R. C., Neal, D., Smith, K., Farndon, J. R., and Wright, C. Epidermal growth factor receptor: a marker of early relapse in breast cancer and tumor stage progression in bladder cancer; interactions with neu. In: M. Furth and M. Greaves (eds.), The Molecular Diagnostics of Human Cancer, pp. 353-357. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
26. Sainsbury, J. R. C., Malcolm, A. J., Appleton, D. R., Farndon, J. R., and Harris, A. L. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J. Clin. Pathol., 38: 1225-1228, 1985.
27. Veale, D., Ashcroft, T., Marsh, C., Gibson, G. J., and Harris, A. L. Epidermal growth factor receptors in non-small cell lung cancer. Br. J. Cancer, 55: 513-516, 1987.
28. Hendler, F., Shum-Siu, A., Nanu, L., Yuan, D., and Ozanne, B. Increased EGF receptors and the absence of an alveolar differentiation marker predict a poor survival in lung cancer. Proc. Am. Clin. Oncol., 8: 223, 1989.
29. Masui, H., Kawamoto, T., Sato, J. D., Wolf, B., Sato, G., and Mendelsohn, J. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res., 44: 1002-1007, 1984.
30. Goldenberg, A., Masui, H., Divgi, C., Kamrath, H., Pentlow, K., and Mendelsohn, J. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody. J. Natl. Cancer Inst., 82: 1616-1625, 1989.
31. Baselga, J., Norton, L., Masui, H., Pandiella, A., Coplan, K., Miller, W. H., Jr., and Mendelsohn, J. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J. Natl. Cancer Inst., 85: 1327-1333, 1993.
32. Baselga, J., Norton, L., Coplan, K., Shalaby, R., and Mendelsohn, J. Antitumor activity of paclitaxel in combination with anti-growth factor receptor monoclonal antibodies in breast cancer xenografts. Proc. Am. Assoc. Cancer Res., 35: 380, 1994.
33. Prewitt, M., Rockwell, P., Rockwell, R. F., Giorgio, N. A., Mendelsohn, J., Scher, H. I., and Goldstein, N. I. The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma. J. Immunother. 19: 419-427, 1996.
34. Brown, C., McNeil, L., Masui, H., and Mendelsohn, J. Cisplatin cytotoxicity is enhanced by treatment with anti-epidermal growth factor receptor monoclonal antibody in squamous carcinoma of the cervix. Society of Gynecologic Oncologists, New Orleans, 1996 (Abstract).
35. Fan, Z., Masui, H., Atlas, I., and Mendelsohn, J. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res., 53: 4322-4328, 1993.
36. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
37. Fan, Z., Lu, Y., Wu, X., and Mendelsohn, J. Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells. J. Biol. Chem., 269: 27595-27602, 1994.
38. Baselga, J., Mendelsohn, J., Kim, Y., and Pandiella, A. Autocrine regulation of membrane transforming growth factor-α cleavage. J. Biol. Chem., 271: 3279-3284, 1996.
39. Hunter, T., and Pines, J. Cyclins and cancer. II. cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
40. Sherr, C. J. G1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
41. 1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. Oncogene, 12: 1397-1403, 1996.
42. Fan, Z., Shang, B. Y., Wu, X., Peng, D., Lu, Y., Chou, J., Koff, A., and Mendelsohn, J. Blockade of epidermal growth factor receptor by anti-EGFR monoclonal antibody 225 causes G1 arrest of A431 cells with induction of p27KIP1. Proc. Am. Assoc. Cancer Res., 17: 10, 1996.
43. Aboud-Pirak, E., Hurwitz, E., Pirak, M. E., Bellot, F., Schlessinger, J., and Sela, M. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J. Natl. Cancer Inst., 80: 1605-1611, 1988.
44. Fan, Z., Baselga, J., Masui, H., and Mendelsohn, J. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts. Cancer Res., 53: 4637-4642, 1993.
45. Meikrantz, W., and Schlegel, R. Apoptosis and the cell cycle. J. Cell Biochem., 58: 160-174, 1995.
46. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
47. Divgi, C. R., Welt, S., Kris, M., Real, F. X., Yeh, S. D. J., Gralla, R., Merchant, B., Schweighart, S., Unger, M., Larson, S. M., and Mendelsohn, J. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J. Natl. Cancer Inst., 83: 97-104, 1991.
48. Bos, M., Mendelsohn, J., Bowden, C., Pfister, D., Cooper, M. R., Cohen, R., Burtness, B., D'Andrea, G., Waksal, H., Norton, L., and Baselga, J. Phase I studies of anti-epidermal growth factor receptor chimeric monoclonal antibody C225 in patients with EGFR overexpressing tumors. Am. Soc. Clin. Oncol., 15: 443, 1996.